Hemostasis and Thrombosis in the Oldest Old

Area of Science:

• Gerontology
• Hematology
• Internal Medicine

Background:

• The aging population presents unique challenges in healthcare, particularly concerning hemostasis.
• Age-related changes in the hemostatic system, including altered coagulation factors and thrombopathy, lead to a hypercoagulable state.
• Comorbidities common in the elderly, such as heart failure, COPD, diabetes, and cancer, further elevate thrombosis risk.

Purpose of the Study:

• To highlight the hemostatic challenges in the elderly population.
• To discuss the increased risk of both thrombotic and bleeding complications in older adults.
• To emphasize the need for a balanced approach to managing hemostasis in geriatric patients.

Main Methods:

• Review of existing literature on hemostasis in aging.
• Analysis of real-life data concerning venous thromboembolism in the elderly.
• Consideration of acquired and congenital bleeding disorders in older individuals.

Main Results:

• Recurrent and fatal venous thromboembolism is a primary hemostatic concern in the elderly.
• The elderly are susceptible to acquired bleeding disorders like acquired hemophilia and von Willebrand syndrome.
• Treatment of thrombotic events in the elderly inherently increases bleeding risk, even with modern anticoagulants.

Conclusions:

• Managing elderly patients requires a careful balance between preventing thrombosis and avoiding bleeding complications.
• The hemostatic system's alterations with age necessitate tailored treatment strategies.
• Achieving a delicate equilibrium between thrombotic and hemorrhagic risks is paramount for optimal geriatric care.